Home Cart Sign in  
Chemical Structure| 743461-65-6 Chemical Structure| 743461-65-6

Structure of Batefenterol
CAS No.: 743461-65-6

Chemical Structure| 743461-65-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Batefenterol is a Muscarinic antagonist and β2-Agonist possessing both muscarinic antagonist (MA) and β2-adrenoceptor agonist (BA) properties (MABA).

Synonyms: GSK961081; TD-5959

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Batefenterol

CAS No. :743461-65-6
Formula : C40H42ClN5O7
M.W : 740.24
SMILES Code : O=C(OC1CCN(CCC(NC2=CC(OC)=C(CNC[C@H](O)C3=CC=C(O)C4=C3C=CC(N4)=O)C=C2Cl)=O)CC1)NC5=CC=CC=C5C6=CC=CC=C6
Synonyms :
GSK961081; TD-5959
MDL No. :MFCD27987925
InChI Key :URWYQGVSPQJGGB-DHUJRADRSA-N
Pubchem ID :10372836

Safety of Batefenterol

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Batefenterol

GPCR

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00478738 Pulmonary Disease, Chronic Obs... More >>tructive Less << PHASE2 COMPLETED 2025-05-08 GSK Investigational Site, Main... More >>z, Rheinland-Pfalz, 55131, Germany|GSK Investigational Site, Berlin, 14050, Germany|GSK Investigational Site, Bloemfontein, 9301, South Africa|GSK Investigational Site, George, 6530, South Africa|GSK Investigational Site, Mowbray, 7700, South Africa Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.35mL

0.27mL

0.14mL

6.75mL

1.35mL

0.68mL

13.51mL

2.70mL

1.35mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories